SEC Filings

SEC Filings
Home / SEC Filings

SEC Filings

PROTALIX BIOTHERAPEUTICS, INC. filed this Form S-8 on 06/08/2018
Entire Document





Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tel Aviv, State of Israel, on June 8, 2018.


  By:  /s/ Moshe Manor
     Moshe Manor
     President and Chief Executive Officer




KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Moshe Manor and Yossi Maimon, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in his or her name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) to the Registration Statement and to file the same, with all exhibits thereto, and all documents in connection therewith, including any subsequent registration statement for the same offering that may be filed under Rule 462(b), with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.


Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.


/s/ Moshe Manor  President, Chief Executive Officer  June 8, 2018
Moshe Manor  (Principal Executive Officer) and Director   
/s/ Yossi Maimon  Chief Financial Officer,  June 8, 2018
Yossi Maimon  Treasurer and Secretary   
   (Principal Financial and Accounting
/s/ Shlomo Yanai  Chairman of the Board  June 8, 2018
Shlomo Yanai      
/s/ Amos Bar Shalev  Director  June 8, 2018
Amos Bar Shalev      
/s/ Zeev Bronfeld  Director  June 8, 2018
Zeev Bronfeld      
/s/ Aharon Schwartz  Director  June 8, 2018
Aharon Schwartz, Ph.D.